alpha-methylhistamine has been researched along with Gastric Diseases in 1 studies
alpha-methylhistamine: a histamine H3 receptor agonist; RN given refers to parent cpd without isomeric designation
alpha-methylhistamine : An aralkylamino compound that is histamine bearing a methyl substituent at the alpha-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palitzsch, KD | 1 |
| Morales, RE | 1 |
| Kronauge, JF | 1 |
| Bynum, TE | 1 |
| Szabo, S | 1 |
1 other study available for alpha-methylhistamine and Gastric Diseases
| Article | Year |
|---|---|
Effect of histamine on haemorrhagic mucosal lesions is related to vascular permeability in rats: studies with histamine, H1-, H2- and H3-agonists and bradykinin.
Topics: Absorption; Animals; Betahistine; Bradykinin; Capillary Permeability; Dimaprit; Dose-Response Relati | 1995 |